Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multi-9 is an approved multivitamin and mineral supplement developed and manufactured by Hab Pharmaceuticals and Research Ltd. It is formulated as an oral tablet containing a combination of essential nutrients, including Vitamin A, D3, B1, B2, B12, nicotinamide, folic acid, zinc sulphate, elemental calcium, and elemental copper. The product is indicated for the prevention and treatment of vitamin and mineral deficiencies, serving as a nutritional supplement for individuals with inadequate dietary intake or increased nutritional requirements. As a small molecule multivitamin complex, it works by replenishing essential micronutrients necessary for various physiological processes, including metabolism, immune function, and bone health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Multi-9.